Literature DB >> 31669367

Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore.

Jada Hackman1, Oluwaseun Falade-Nwulia2, Eshan U Patel3, Shruti H Mehta2, Gregory D Kirk4, Jacquie Astemborski2, Stuart C Ray5, David L Thomas4, Oliver Laeyendecker6.   

Abstract

This study examines correlates of hepatitis C virus (HCV) genetic clustering among community-recruited people who inject drugs enrolled in the AIDS Linked to the IntraVenous Experience cohort in Baltimore between 1988 and 1989. HCV RNA was extracted and the core/envelope-1 region was sequenced. Clusters were identified from maximum likelihood trees with 1000 bootstrap replicates using a 70% aLRT and a 4% genetic-distance threshold in Cluster Picker. Overall, 46% of participants were in a cluster, including 122 genotype-1a and 36 genotype-1b clusters with an average of 2-3 genetically linked HCV infections. The largest cluster consists of 9 participants. In univariable analysis, black race (PR = 1.66 [95% CI: 1.12-2.45]), age <35 years (PR = 1.18 [95% CI: 1.02-1.37]), and injection drug use of cocaine alone (PR = 1.30 [95% CI: 1.02-1.65]) were significantly associated with being in a cluster. Conversely, a history of medication-associated treatment (MAT) was negatively associated with being in a cluster (PR = 0.82 [95% CI: 0.71-0.95]). In multivariable analysis, black race (APR = 1.62 [95% CI: 1.11-2.38]) remained independently associated being in a cluster while MAT (APR = 0.85 [95% CI: 0.74-0.99]) remained negatively associated with clustering. Our findings suggest strong locally-propagated transmission networks during the early epidemic that was driven by younger PWID. In light of the current opioid epidemic in the US, these findings suggest an urgent need for preventive interventions to mitigate the growth of large HCV transmission networks. Published by Elsevier B.V.

Entities:  

Keywords:  1CE; Hepatitis C virus; Injection drug use; Molecular epidemiology; PWID; Phylogenetic

Mesh:

Year:  2019        PMID: 31669367      PMCID: PMC7460273          DOI: 10.1016/j.meegid.2019.104078

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  49 in total

Review 1.  The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review.

Authors:  Michelle Gillies; Norah Palmateer; Sharon Hutchinson; Syed Ahmed; Avril Taylor; David Goldberg
Journal:  BMC Public Health       Date:  2010-11-23       Impact factor: 3.295

Review 2.  Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-12-16

3.  Complex patterns of Hepatitis-C virus longitudinal clustering in a high-risk population.

Authors:  Rebecca Rose; Susanna L Lamers; Guido Massaccesi; William Osburn; Stuart C Ray; David L Thomas; Andrea L Cox; Oliver Laeyendecker
Journal:  Infect Genet Evol       Date:  2017-12-16       Impact factor: 3.342

4.  Young people and injection drug use: Is there a need to expand harm reduction services and support?

Authors:  Kelly Adamson; Lois Jackson; Jacqueline Gahagan
Journal:  Int J Drug Policy       Date:  2016-10-19

5.  The spread of hepatitis C virus genotype 1a in North America: a retrospective phylogenetic study.

Authors:  Jeffrey B Joy; Rosemary M McCloskey; Thuy Nguyen; Richard H Liang; Yury Khudyakov; Andrea Olmstead; Mel Krajden; John W Ward; P Richard Harrigan; Julio S G Montaner; Art F Y Poon
Journal:  Lancet Infect Dis       Date:  2016-03-30       Impact factor: 25.071

6.  New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1.

Authors:  J C Anthony; D Vlahov; K E Nelson; S Cohn; J Astemborski; L Solomon
Journal:  Am J Epidemiol       Date:  1991-11-15       Impact factor: 4.897

7.  Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data.

Authors:  Matthew Kearse; Richard Moir; Amy Wilson; Steven Stones-Havas; Matthew Cheung; Shane Sturrock; Simon Buxton; Alex Cooper; Sidney Markowitz; Chris Duran; Tobias Thierer; Bruce Ashton; Peter Meintjes; Alexei Drummond
Journal:  Bioinformatics       Date:  2012-04-27       Impact factor: 6.937

8.  A large HCV transmission network enabled a fast-growing HIV outbreak in rural Indiana, 2015.

Authors:  Sumathi Ramachandran; Hong Thai; Joseph C Forbi; Romeo Regi Galang; Zoya Dimitrova; Guo-Liang Xia; Yulin Lin; Lili T Punkova; Pamela R Pontones; Jessica Gentry; Sara J Blosser; Judith Lovchik; William M Switzer; Eyasu Teshale; Philip Peters; John Ward; Yury Khudyakov
Journal:  EBioMedicine       Date:  2018-11-15       Impact factor: 8.143

9.  Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007.

Authors:  Barbara Tempalski; Enrique R Pouget; Charles M Cleland; Joanne E Brady; Hannah L F Cooper; H Irene Hall; Amy Lansky; Brooke S West; Samuel R Friedman
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

Review 10.  Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review.

Authors:  Rachel M Murdock; Marisa B Brizzi; Omar Perez; Melissa E Badowski
Journal:  Infect Dis Ther       Date:  2019-01-03
View more
  4 in total

1.  Identification of Genetically Related HCV Infections Among Self-Described Injecting Partnerships.

Authors:  Damien C Tully; Judith A Hahn; David J Bean; Jennifer L Evans; Meghan D Morris; Kimberly Page; Todd M Allen
Journal:  Clin Infect Dis       Date:  2022-03-23       Impact factor: 20.999

2.  Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore.

Authors:  Oluwaseun Falade-Nwulia; Jada Hackman; Shruti H Mehta; Sean D McCormick; Gregory D Kirk; Mark Sulkowski; David Thomas; Carl Latkin; Oliver Laeyendecker; Stuart C Ray
Journal:  BMC Infect Dis       Date:  2020-11-10       Impact factor: 3.090

3.  Hepatitis C Virus Transmission Clusters in Public Health and Correctional Settings, Wisconsin, USA, 2016-20171.

Authors:  Karli R Hochstatter; Damien C Tully; Karen A Power; Ruth Koepke; Wajiha Z Akhtar; Audrey F Prieve; Thomas Whyte; David J Bean; David W Seal; Todd M Allen; Ryan P Westergaard
Journal:  Emerg Infect Dis       Date:  2021-02       Impact factor: 6.883

4.  Molecular Epidemiology and Baseline Resistance of Hepatitis C Virus to Direct Acting Antivirals in Croatia.

Authors:  Petra Simicic; Anamarija Slovic; Leona Radmanic; Adriana Vince; Snjezana Zidovec Lepej
Journal:  Pathogens       Date:  2022-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.